Gain-of-"endocytic' function in mutant p53 cancer cells

Int J Biochem Cell Biol. 2021 Feb:131:105905. doi: 10.1016/j.biocel.2020.105905. Epub 2020 Dec 24.

Abstract

Beyond its well-known canonical function as a tumor suppressor, p53 is also involved in numerous cellular processes through altered transcription under both normal and pathological conditions. The functional diversity of p53 outputs is complex and dependent on cell context. However, the underlying mechanisms responsible for this diversity remain largely unclear. The emerging evidence of p53 mutations involved in regulating endocytic trafficking and signaling, in tandem to promote malignancy (invasion, exosome biogenesis and immune evasion), sheds light on possible mechanisms behind the p53-driven complexity. The interrelated nature of endocytic trafficking and receptor signaling that form dynamic and adaptable feedback loops - either positive or negative - functions to modulate multiple cellular outputs. Biasing the tunable endocytic trafficking and receptor signaling network by mutant p53 expands the purview of p53, allowing its contribution to diverse and aggressive phenotypes. In this review, we explore recent studies in which the novel role of mutant p53 in altering endocytic trafficking to bias receptor signaling and drive transforming phenotypes is revealed. Understanding the complex crosstalk of mutant p53, endocytic trafficking and receptor signaling will allow the development of therapies to selectively target p53-altered endocytic processes.

Keywords: Cell invasion; Exosome; Immune evasion; Mutant p53; Receptor recycling; Receptor tyrosine kinase; Signaling.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cell Cycle / genetics
  • Cell Line, Tumor
  • Cell Movement
  • Cell Proliferation
  • DEAD-box RNA Helicases / genetics
  • DEAD-box RNA Helicases / immunology
  • Endocytosis / genetics*
  • Endosomes / genetics
  • Endosomes / metabolism
  • ErbB Receptors / genetics
  • ErbB Receptors / immunology
  • Gain of Function Mutation*
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Integrin beta1 / genetics*
  • Integrin beta1 / immunology
  • Lung Neoplasms / genetics*
  • Lung Neoplasms / immunology
  • Lung Neoplasms / pathology
  • Ribonuclease III / genetics
  • Ribonuclease III / immunology
  • Signal Transduction
  • Tumor Escape
  • Tumor Suppressor Protein p53 / genetics*
  • Tumor Suppressor Protein p53 / immunology

Substances

  • Integrin beta1
  • Itgb1 protein, human
  • Tumor Suppressor Protein p53
  • EGFR protein, human
  • ErbB Receptors
  • DICER1 protein, human
  • Ribonuclease III
  • DEAD-box RNA Helicases